Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS)
CUSIP: 15117K103
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Ordinary Shares, nominal value EUR0.05 per share
- Shares outstanding
- 95,490,450
- Total 13F shares
- 5,258,779
- Share change
- -445,163
- Total reported value
- $135,752,000
- Put/Call ratio
- 135%
- Price per share
- $25.82
- Number of holders
- 39
- Value change
- -$10,905,829
- Number of buys
- 20
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 15117K103?
CUSIP 15117K103 identifies CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 15117K103:
Top shareholders of CLLS - Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.7%
|
3,530,406
|
$84,730,000 | — | 31 Mar 2017 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.37%
|
350,000
|
$8,400,000 | — | 31 Mar 2017 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.32%
|
310,250
|
$7,446,000 | — | 31 Mar 2017 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.31%
|
299,034
|
$7,176,000 | — | 31 Mar 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.26%
|
243,700
|
$5,849,000 | — | 31 Mar 2017 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.17%
|
159,664
|
$3,832,000 | — | 31 Mar 2017 | |
| Artal Group S.A. |
13F
|
Company |
0.16%
|
150,000
|
$3,600,000 | — | 31 Mar 2017 | |
| Abingworth LLP |
13F
|
Company |
0.1%
|
100,000
|
$2,400,000 | — | 31 Mar 2017 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.1%
|
97,096
|
$2,330,000 | — | 31 Mar 2017 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.08%
|
76,404
|
$1,834,000 | — | 31 Mar 2017 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
55,635
|
$1,335,000 | — | 31 Mar 2017 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.05%
|
50,994
|
$1,224,000 | — | 31 Mar 2017 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.05%
|
50,000
|
$1,200,000 | — | 31 Mar 2017 | |
| GAM Holding AG |
13F
|
Company |
0.05%
|
44,833
|
$1,079,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
34,817
|
$835,000 | — | 31 Mar 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
29,477
|
$707,000 | — | 31 Mar 2017 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
24,158
|
$580,000 | — | 31 Mar 2017 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.01%
|
13,609
|
$327,000 | — | 31 Mar 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
13,026
|
$313,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
10,210
|
$245,000 | — | 31 Mar 2017 | |
| PICTON MAHONEY ASSET MANAGEMENT |
13F
|
Company |
0.01%
|
10,200
|
$245,000 | — | 31 Mar 2017 | |
| Trexquant Investment LP |
13F
|
Company |
0.01%
|
8,919
|
$214,000 | — | 31 Mar 2017 | |
| Freedom Investment Management, Inc. |
13F
|
Company |
0.01%
|
8,400
|
$202,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
7,890
|
$189,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
5,400
|
$129,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
4,115
|
$99,000 | — | 31 Mar 2017 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
4,000
|
$96,000 | — | 31 Mar 2017 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
3,215
|
$77,000 | — | 31 Mar 2017 | |
| ARK Investment Management LLC |
13F
|
Company |
0%
|
2,254
|
$54,000 | — | 31 Mar 2017 | |
| PRIVATE CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
2,200
|
$53,000 | — | 31 Mar 2017 | |
| FNY Partners Fund LP |
13F
|
Company |
0%
|
1,500
|
$36,000 | — | 31 Mar 2017 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0%
|
500
|
$12,000 | — | 31 Mar 2017 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0%
|
400
|
$10,000 | — | 31 Mar 2017 | |
| ADVANTAGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0%
|
200
|
$5,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
200
|
$5,000 | — | 31 Mar 2017 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
170
|
$4,000 | — | 31 Mar 2017 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0%
|
150
|
$3,000 | — | 31 Mar 2017 | |
| OPPENHEIMER ASSET MANAGEMENT INC. |
13F
|
Company |
0%
|
140
|
$3,000 | — | 31 Mar 2017 | |
| MAGEE THOMSON INVESTMENT PARTNERS LLC |
13F
|
Company |
0%
|
26
|
$1,000 | — | 31 Mar 2017 |
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2017
As of 30 Jun 2017,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,258,779 shares.
The largest 10 holders included
FMR LLC, Tekla Capital Management LLC, LAZARD ASSET MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., Abingworth LLP, Artal Group S.A., venBio Select Advisor LLC, DAFNA Capital Management LLC, MORGAN STANLEY, and ORBIMED ADVISORS LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
39
Q2 2017 holders
39
Holder diff
0
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.